概括
糖原储存疾病 (GSD) 是一种遗传性代谢障碍,导致糖原的积累. 早期诊断和个性化治疗是管理GSD症状和改善患者结果的关键.
科学领域:
- 生物化学 生物化学
- 遗传学 遗传学 是一个
- 儿科 儿科 儿科
背景情况:
- 糖原储存疾病 (GSD) 包含一组遗传性代谢障碍.
- 这些疾病是由酶缺乏影响碳水化合物代谢并导致肝脏,肌肉和心脏等器官中异常的糖原积累引起的.
- 临床表现包括低血糖,肝炎,肌肉衰弱和心脏功能障碍,因GSD类型和受影响系统而异.
研究的目的:
- 提供关于糖原储存疾病 (GSD) 的全面审查.
- 涵盖分子机制,临床表现,诊断方法和当前的治疗策略.
- 讨论GSD的挑战和未来的研究方向.
主要方法:
- 文献综述侧重于GSD的分子遗传学,病理生理学和临床方面.
- 分析当前的治疗方式,包括饮食管理,酶替代疗法和遗传疗法.
- 检查治疗坚持和长期结果的挑战.
主要成果:
- 分子遗传学显著改善了GSD诊断和对病理生理学的理解.
- 存在各种各样的GSD类型,每个类型都与特定的酶缺乏和不同的临床表型有关.
- 目前的治疗方法包括饮食,酶替代和新兴的基因疗法,并正在研究更有效的选择.
结论:
- 早期诊断和个性化治疗计划对于改善GSD患者预后至关重要.
- 解决治疗坚持和长期护理方面的挑战至关重要.
- 持续的研究对于开发新型疗法和实现治愈GSD至关重要.
相关概念视频
Overview of Carbohydrate Metabolism
3.2K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
3.2K
Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Hypoglycemia and Glucagon
778
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
778
Diabetes: Management and Pharmacotherapy
848
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
848
Inborn Errors of Metabolism
683
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
683


